Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19
Viruses · 20.02.2023 · 15 (2) · 578
DOI: 10.3390/v15020578 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 20.02.2023. Verfasst von Mi Il Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Dongguk University-Seoul, Goyang 10326, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19, Coronavirus OC43, Human. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST), Dongguk University Research Fund of 2021.
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID-19) pandemic has had irreversible and devastating impacts on every aspect of human life. To better prepare for the next similar pandemic, a clear understanding of coronavirus biology is a prerequisite. Nevertheless, the high-risk nature of the causative agent of COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), requires the use of a cumbersome biosafety level-3 (BSL-3) confinement facility. To facilitate the development of preventive and therapeutic measures against SARS-CoV-2, one of the endemic strains of low-risk coronaviruses has gained attention as a useful research alternative: human coronavirus OC43 (HCoV-OC43). In this review, its history, classification, and clinical manifestations are first summarized. The characteristics of its viral genomes, genes, and evolution process are then further explained. In addition, the host factors necessary to support the life cycle of HCoV-OC43 and the innate, as well as adaptive, immunological responses to HCoV-OC43 infection are discussed. Finally, the development of in vitro and in vivo systems to study HCoV-OC43 and its application to the discovery of potential antivirals for COVID-19 by using HCoV-OC43 models are also presented. This review should serve as a concise guide for those who wish to use HCoV-OC43 to study coronaviruses in a low-risk research setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Dongguk University-Seoul, Goyang 10326, Republic of Korea.
ORCID-Profile: Choongho Lee
Förderung
- National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST)
- Dongguk University Research Fund of 2021
Zitieren
APA
Kim, M. I., & Lee, C. (2023). Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19. Viruses, 15(2), 578. https://doi.org/10.3390/v15020578
Vancouver
Kim MI, Lee C. Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19. Viruses. 2023;15(2):578. doi:10.3390/v15020578
BibTeX
@article{Kim2023,
author = {Kim, Mi Il and Lee, Choongho},
title = {Human Coronavirus OC43 as a Low-Risk Model to Study COVID-19},
journal = {Viruses},
year = {2023},
volume = {15},
number = {2},
pages = {578},
doi = {10.3390/v15020578}
}
EUVIMED